Showing results (181-190 of 198) with videos related to

Sort By:
Pageof 20
JAMA|November 7, 2025
SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria: A Meta-AnalysisBrendon L Neuen, Robert A Fletcher, Stefan D Anker, et al.
Journal of Cardiac Failure|February 27, 2025
Epidemiology and Prognostic Significance of Acute Noncardiac Organ Dysfunction Across Cardiogenic Shock SubtypesAnubodh S Varshney, Michael G Palazzolo, Christopher F Barnett, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Common genetic variants near SLC2A2 and glycemic response to glimepiride in the GRADE comparative effectiveness clinical trialJosephine H Li, Lukasz Szczerbinski, Mark Tripputi, et al.
Nature Reviews. Cardiology|March 11, 2026
Antiphospholipid antibodies and cardiovascular thrombosisSina Rashedi, Hannah Leyva, Saman A Siddiqui, et al.
Circulation. Heart Failure|May 7, 2026
Variation in Vasoactive Treatment Selection for Cardiogenic Shock: Insights From the Critical Care Cardiology Trials Network (CCCTN)David E Hamilton, Jackson L Shriver, Siddharth M Patel, et al.
Nature Communications|August 30, 2022
Endophenotype effect sizes support variant pathogenicity in monogenic disease susceptibility genesJennifer L Halford, Valerie N Morrill, Seung Hoan Choi, et al.
European Heart Journal. Acute Cardiovascular Care|August 28, 2023
Prognostic significance of haemodynamic parameters in patients with cardiogenic shockDavid D Berg, Gurleen Kaur, Erin A Bohula, et al.
Journal of the American College of Cardiology|April 22, 2026
Body Mass Index, Clinical Outcomes, and Mortality in Heart Failure: A Mendelian Randomization StudyNicholas Sunderland, Geraldine Asselin, Albert Henry, et al.
Pageof 20